Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-21-151732
Filing Date
2021-05-05
Accepted
2021-05-05 16:15:28
Documents
62
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d320835d10q.htm   iXBRL 10-Q 1429256
2 EX-10.1 d320835dex101.htm EX-10.1 826528
3 EX-31.1 d320835dex311.htm EX-31.1 11118
4 EX-31.2 d320835dex312.htm EX-31.2 10697
5 EX-32.1 d320835dex321.htm EX-32.1 5751
11 GRAPHIC g320835g0428110346098.jpg GRAPHIC 3097
  Complete submission text file 0001193125-21-151732.txt   6154100

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA gbt-20210331.xsd EX-101.SCH 36685
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gbt-20210331_cal.xml EX-101.CAL 43850
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gbt-20210331_def.xml EX-101.DEF 166906
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE gbt-20210331_lab.xml EX-101.LAB 362263
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gbt-20210331_pre.xml EX-101.PRE 286500
12 EXTRACTED XBRL INSTANCE DOCUMENT d320835d10q_htm.xml XML 685270
Mailing Address 181 OYSTER POINT BLVD SOUTH SAN FRANCISCO CA 94080
Business Address 181 OYSTER POINT BLVD SOUTH SAN FRANCISCO CA 94080 650741-7700
Global Blood Therapeutics, Inc. (Filer) CIK: 0001629137 (see all company filings)

EIN.: 274825712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37539 | Film No.: 21893445
SIC: 2834 Pharmaceutical Preparations